MedTrace Logo

Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics

NCT06102655 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-12-05

No results posted yet for this study

Summary

1. Identify differential metabolites in POI patients.
2. Analysis of differential metabolites and their involved mechanism pathways.

Conditions

  • Premature Ovarian Insufficiency
  • Metabolomics
  • Traditional Chinese Medicine
  • Mechanism
  • Clinical Syndrome

Interventions

DRUG

Jiajian Guishen Formulation

Jiajian Guishen Formulation is a formulation of Traditional Chinese Medicine.POI patients will be treat with Jiajian Guishen Formulation for three menstrual cycles; their blood samples are collected before and after treatment.No drug will be used in control group, and their blood samples are collected when join the experiment.

Sponsors & Collaborators

  • Shi Yun

    lead OTHER

Principal Investigators

  • Yun Shi · Dongzhimen Hospital of Beijing University of Chinese Medicine

  • Ke Xu, Master · Dongzhimen Hospital of Beijing University of Chinese Medicine

  • Jing yi Shao, Master · Dongzhimen Hospital of Beijing University of Chinese Medicine

  • Xi yu Li, Bachelor · Dongzhimen Hospital of Beijing University of Chinese Medicine

  • Qin yang Liu, Bachelor · Dongzhimen Hospital of Beijing University of Chinese Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2024-07-20
Completion
2024-07-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06102655 on ClinicalTrials.gov